Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Mustard Gas
The Rheumatoid Arthritis-Associated Citrullinome.
Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology.
Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis.
See All 8 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis.
Podolanczuk AJ, Richeldi L, Martinez FJ. The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis. JAMA. 2023 05 09; 329(18):1554-1555.
View in:
PubMed
subject areas
Clinical Trials as Topic
Forecasting
Humans
Idiopathic Pulmonary Fibrosis
authors with profiles
Fernando J Martinez MD, MS